Celldex Therapeutics
CLDX
CLDX
135 hedge funds and large institutions have $1.31B invested in Celldex Therapeutics in 2014 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 52 increasing their positions, 43 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
57% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 37
Holders
135
Holding in Top 10
1
Calls
$16.9M
Puts
$33.9M
Top Buyers
| 1 | +$49.1M | |
| 2 | +$29.7M | |
| 3 | +$21.5M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$19.9M |
| 5 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$15.1M |
Top Sellers
| 1 | -$24.9M | |
| 2 | -$15.4M | |
| 3 | -$15.3M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$10.2M |
| 5 |
CCI
Columbus Circle Investors
|
-$5.98M |